FW
RMD icon

FullCircle Wealth’s ResMed RMD Stock Holding History

FullCircle Wealth’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$260K Buy
1,057
+20
+2% +$5.46K 0.09% 218
2025
Q2 		$302K Buy
1,037
+69
+7% +$16.5K 0.11% 188
2025
Q1 		$227K Buy
+968
New +$226K 0.09% 210

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

FullCircle Wealth's RMD Position: Q3 2025 in Review

FullCircle Wealth increased its ResMed (RMD) stake by 1.9% in Q3 2025, buying an estimated $5.46K and bringing the position to 1,057 shares worth $260K. The position accounts for 0.09% of the portfolio, ranked #218.

FullCircle Wealth first reported a position in RMD in Q1 2025 and has held it in 3 quarters since. The position peaked at $302K in Q2 2025. 949 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • FullCircle Wealth held 1,057 shares of ResMed worth $260K as of Q3 2025.
  • FullCircle Wealth bought 20 ResMed shares in Q3 2025, an estimated $5.46K.
  • ResMed made up 0.09% of FullCircle Wealth's portfolio in Q3 2025, its #218 holding.
  • FullCircle Wealth first reported a position in ResMed in Q1 2025 and has held it in 3 quarters since.
  • FullCircle Wealth's ResMed position peaked at $302K in Q2 2025.
  • 949 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on FullCircle Wealth's 13F filing for Q3 2025, filed 5 Nov 2025.